AmyriAD
Manufacturing · Oregon, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
21370 SW Langer Farms Pkwy Ste 142-114, ...Website
www.amyriadtherapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About AmyriAD
AmyriAD is focused on developing Ismidenon, a novel oral therapy aimed at improving cognition and global function in patients with Alzheimer's disease. The company is advancing next-generation therapies to address the complexities of Alzheimer's, particularly the acetylcholine deficiency that affects cognitive function and memory. With a leadership team experienced in Alzheimer's drug development, AmyriAD is committed to enhancing patient outcomes while minimizing side effects. Their lead candidate, Ismidenon, is currently preparing for a Phase 2/3 registration trial in the US.Explore more
AmyriAD Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is AmyriAD your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on AmyriAD recently announced quarterly report
Check if AmyriAD has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once AmyriAD has new funding data
Congratulate Masked Content for being promoted to Masked Content at AmyriAD
AmyriAD, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if AmyriAD had a recent Job posting/layoffs
Product Launch: Get notified when AmyriAD launches new products
Website visits: Recent activity has been detected on your website
Check out if AmyriAD is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined AmyriAD as Masked Content
Find more new buyers
Compare Similar Companies to AmyriAD
Compare insights from companies similar to AmyriAD, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
AmyriAD is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
AmyriAD is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about AmyriAD.
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding AmyriAD
Sign Up For FreeTo access detailed company insights
AmyriAD is focused on developing Ismidenon, a novel oral therapy aimed at improving cognition and global function in patients with Alzheimer's disease. The company is advancing next-generation therapies to address the complexities of Alzheimer's, particularly the acetylcholine deficiency that affects cognitive function and memory. With a leadership... Read More
